ID   CAC1C_RAT               Reviewed;        2169 AA.
AC   P22002; P27733; P27734; Q62816; Q63271; Q64178;
DT   01-AUG-1991, integrated into UniProtKB/Swiss-Prot.
DT   01-AUG-1991, sequence version 1.
DT   02-OCT-2024, entry version 201.
DE   RecName: Full=Voltage-dependent L-type calcium channel subunit alpha-1C;
DE   AltName: Full=Calcium channel, L type, alpha-1 polypeptide, isoform 1, cardiac muscle;
DE   AltName: Full=Rat brain class C {ECO:0000303|PubMed:1648941};
DE            Short=RBC {ECO:0000303|PubMed:1648941};
DE   AltName: Full=Voltage-gated calcium channel subunit alpha Cav1.2;
GN   Name=Cacna1c; Synonyms=Cach2, Cacn2, Cacnl1a1, Cchl1a1;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2).
RC   TISSUE=Aorta;
RX   PubMed=2170396; DOI=10.1016/s0021-9258(18)38232-2;
RA   Koch W.J., Ellinor P.T., Schwartz A.;
RT   "cDNA cloning of a dihydropyridine-sensitive calcium channel from rat
RT   aorta. Evidence for the existence of alternatively spliced forms.";
RL   J. Biol. Chem. 265:17786-17791(1990).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 4 AND 5), FUNCTION, AND SUBCELLULAR
RP   LOCATION.
RC   TISSUE=Brain;
RX   PubMed=1648941; DOI=10.1016/0896-6273(91)90073-9;
RA   Snutch T.P., Tomlinson W.J., Leonard J.P., Gilbert M.M.;
RT   "Distinct calcium channels are generated by alternative splicing and are
RT   differentially expressed in the mammalian CNS.";
RL   Neuron 7:45-57(1991).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1168-1413 (ISOFORM 1).
RX   PubMed=1692134; DOI=10.1073/pnas.87.9.3391;
RA   Snutch T.P., Leonard J.P., Gilbert M.M., Lester H.A., Davidson N.;
RT   "Rat brain expresses a heterogeneous family of calcium channels.";
RL   Proc. Natl. Acad. Sci. U.S.A. 87:3391-3395(1990).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1269-1415 (ISOFORMS 1; 2 AND 3).
RX   PubMed=1311102; DOI=10.1073/pnas.89.4.1497;
RA   Diebold R.J., Koch W.J., Ellinor P.T., Wang J.-J., Muthuchamy M.,
RA   Wieczorek D.F., Schwartz A.;
RT   "Mutually exclusive exon splicing of the cardiac calcium channel a1 subunit
RT   generates developmentally regulated isoforms in the rat heart.";
RL   Proc. Natl. Acad. Sci. U.S.A. 89:1497-1501(1992).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1269-1387.
RC   TISSUE=Myometrium;
RX   PubMed=7485440; DOI=10.1152/ajpcell.1995.269.4.c1008;
RA   Tezuka N., Ali M., Chwalisz K., Garfield R.E.;
RT   "Changes in transcripts encoding calcium channel subunits of rat myometrium
RT   during pregnancy.";
RL   Am. J. Physiol. 269:C1008-C1017(1995).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1202-1495 (ISOFORM 3).
RC   TISSUE=Osteosarcoma;
RX   PubMed=7479909; DOI=10.1073/pnas.92.24.10914;
RA   Barry E.L.R., Gesek F.A., Froehner S.C., Friedman P.A.;
RT   "Multiple calcium channel transcripts in rat osteosarcoma cells: selective
RT   activation of alpha 1D isoform by parathyroid hormone.";
RL   Proc. Natl. Acad. Sci. U.S.A. 92:10914-10918(1995).
RN   [7]
RP   PHOSPHORYLATION.
RX   PubMed=8396138; DOI=10.1016/s0021-9258(19)36536-6;
RA   Hell J.W., Yokoyama C.T., Wong S.T., Warner C., Snutch T.P.,
RA   Catterall W.A.;
RT   "Differential phosphorylation of two size forms of the neuronal class C L-
RT   type calcium channel alpha 1 subunit.";
RL   J. Biol. Chem. 268:19451-19457(1993).
RN   [8]
RP   INTERACTION WITH CACNA2D1.
RX   PubMed=9278523; DOI=10.1523/jneurosci.17-18-06884.1997;
RA   Felix R., Gurnett C.A., De Waard M., Campbell K.P.;
RT   "Dissection of functional domains of the voltage-dependent Ca2+ channel
RT   alpha2delta subunit.";
RL   J. Neurosci. 17:6884-6891(1997).
RN   [9]
RP   INTERACTION WITH CABP1, FUNCTION, ACTIVITY REGULATION, SUBCELLULAR
RP   LOCATION, AND TISSUE SPECIFICITY.
RX   PubMed=15140941; DOI=10.1523/jneurosci.5523-03.2004;
RA   Zhou H., Kim S.-A., Kirk E.A., Tippens A.L., Sun H., Haeseleer F., Lee A.;
RT   "Ca2+-binding protein-1 facilitates and forms a postsynaptic complex with
RT   Cav1.2 (L-type) Ca2+ channels.";
RL   J. Neurosci. 24:4698-4708(2004).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-845; SER-1699 AND SER-1720,
RP   AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
RN   [11]
RP   INTERACTION WITH CACNB3.
RX   PubMed=24751537; DOI=10.1083/jcb.201304101;
RA   Beguin P., Nagashima K., Mahalakshmi R.N., Vigot R., Matsunaga A., Miki T.,
RA   Ng M.Y., Ng Y.J., Lim C.H., Tay H.S., Hwang L.A., Firsov D., Tang B.L.,
RA   Inagaki N., Mori Y., Seino S., Launey T., Hunziker W.;
RT   "BARP suppresses voltage-gated calcium channel activity and Ca2+-evoked
RT   exocytosis.";
RL   J. Cell Biol. 205:233-249(2014).
RN   [12]
RP   X-RAY CRYSTALLOGRAPHY (2.6 ANGSTROMS) OF 452-476 IN COMPLEX WITH CACNB3,
RP   FUNCTION, AND REGION.
RX   PubMed=15170217; DOI=10.1038/nature02641;
RA   Chen Y.H., Li M.H., Zhang Y., He L.L., Yamada Y., Fitzmaurice A., Shen Y.,
RA   Zhang H., Tong L., Yang J.;
RT   "Structural basis of the alpha1-beta subunit interaction of voltage-gated
RT   Ca2+ channels.";
RL   Nature 429:675-680(2004).
CC   -!- FUNCTION: Pore-forming, alpha-1C subunit of the voltage-gated calcium
CC       channel that gives rise to L-type calcium currents (Probable)
CC       (PubMed:15140941, PubMed:15170217). Mediates influx of calcium ions
CC       into the cytoplasm, and thereby triggers calcium release from the
CC       sarcoplasm (By similarity). Plays an important role in excitation-
CC       contraction coupling in the heart (By similarity). Required for normal
CC       heart development and normal regulation of heart rhythm (By
CC       similarity). Required for normal contraction of smooth muscle cells in
CC       blood vessels and in the intestine. Essential for normal blood pressure
CC       regulation via its role in the contraction of arterial smooth muscle
CC       cells (By similarity). Long-lasting (L-type) calcium channels belong to
CC       the 'high-voltage activated' (HVA) group (By similarity).
CC       {ECO:0000250|UniProtKB:P15381, ECO:0000250|UniProtKB:Q01815,
CC       ECO:0000250|UniProtKB:Q13936, ECO:0000269|PubMed:15140941,
CC       ECO:0000269|PubMed:15170217, ECO:0000305|PubMed:1648941}.
CC   -!- ACTIVITY REGULATION: Inhibited by dihydropyridines (DHP), such as
CC       isradipine (By similarity). Inhibited by nifedipine (By similarity).
CC       Channel activity is regulated by Ca(2+) and calmodulin
CC       (PubMed:15140941). Binding of STAC1, STAC2 or STAC3 to a region that
CC       overlaps with the calmodulin binding site inhibits channel inactivation
CC       by Ca(2+) and calmodulin (By similarity). Binding of calmodulin or
CC       CABP1 at the same regulatory sites results in opposite effects on the
CC       channel function (PubMed:15140941). Shear stress and pressure increases
CC       calcium channel activity (By similarity).
CC       {ECO:0000250|UniProtKB:P15381, ECO:0000250|UniProtKB:Q13936,
CC       ECO:0000269|PubMed:15140941}.
CC   -!- SUBUNIT: Component of a calcium channel complex consisting of a pore-
CC       forming alpha subunit (CACNA1C) and ancillary beta, gamma and delta
CC       subunits (PubMed:15170217). The channel complex contains alpha, beta,
CC       gamma and delta subunits in a 1:1:1:1 ratio, i.e. it contains only one
CC       of each type of subunit. CACNA1C channel activity is modulated by
CC       ancillary subunits, such as CACNB1, CACNB2, CACNB3, CACNA2D1 and
CC       CACNA2D4 (By similarity). Interacts with the gamma subunits CACNG4,
CC       CACNG6, CACNG7 and CACNG8 (By similarity). Interacts with CACNB1 (By
CC       similarity). Interacts with CACNB2. Identified in a complex with
CC       CACNA2D4 and CACNB3 (By similarity). Interacts with CACNB3
CC       (PubMed:15170217, PubMed:24751537). Interacts with CACNA2D1. Interacts
CC       with CACNA2D4. Interacts with CALM1. Interacts (via the N-terminus and
CC       the C-terminal C and IQ motifs) with CABP1; this inhibits Ca(2+)-
CC       dependent channel inactivation (PubMed:15140941). The binding via the C
CC       motif is calcium independent whereas the binding via IQ requires the
CC       presence of calcium and is mutually exclusive with calmodulin binding
CC       (PubMed:15140941). The binding to the cytoplasmic N-terminal domain is
CC       calcium independent but is essential for the channel modulation.
CC       Interacts (via C-terminal CDB motif) with CABP5; in a calcium-dependent
CC       manner. Interacts with CIB1; the interaction increases upon
CC       cardiomyocytes hypertrophy (By similarity). Interacts with STAC2 and
CC       STAC3; this inhibits channel inactivation (By similarity).
CC       {ECO:0000250|UniProtKB:P15381, ECO:0000250|UniProtKB:Q01815,
CC       ECO:0000250|UniProtKB:Q13936, ECO:0000269|PubMed:15140941,
CC       ECO:0000269|PubMed:15170217, ECO:0000269|PubMed:24751537}.
CC   -!- INTERACTION:
CC       P22002; P63329: Ppp3ca; NbExp=5; IntAct=EBI-1185084, EBI-7022944;
CC       P22002; Q9WUD9: Src; NbExp=4; IntAct=EBI-1185084, EBI-7784541;
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:15140941,
CC       ECO:0000269|PubMed:15170217, ECO:0000305|PubMed:1648941}; Multi-pass
CC       membrane protein {ECO:0000305}. Cell membrane, sarcolemma
CC       {ECO:0000250|UniProtKB:P15381}; Multi-pass membrane protein
CC       {ECO:0000305}. Perikaryon {ECO:0000269|PubMed:15140941}. Postsynaptic
CC       density membrane {ECO:0000269|PubMed:15140941}. Cell projection,
CC       dendrite {ECO:0000269|PubMed:15140941}. Cell membrane, sarcolemma, T-
CC       tubule {ECO:0000250|UniProtKB:Q01815}. Note=Colocalizes with ryanodine
CC       receptors in distinct clusters at the junctional membrane, where the
CC       sarcolemma and the sarcoplasmic reticulum are in close contact. The
CC       interaction between RRAD and CACNB2 promotes the expression of CACNA1C
CC       at the cell membrane. {ECO:0000250|UniProtKB:P15381}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=5;
CC         Comment=Additional isoforms seem to exist.;
CC       Name=2; Synonyms=S3B;
CC         IsoId=P22002-1; Sequence=Displayed;
CC       Name=1; Synonyms=S3A;
CC         IsoId=P22002-2; Sequence=VSP_000911;
CC       Name=3; Synonyms=D1, ROB2;
CC         IsoId=P22002-3; Sequence=VSP_000912;
CC       Name=4; Synonyms=rbC-I;
CC         IsoId=P22002-4; Sequence=VSP_000908, VSP_000910, VSP_000911;
CC       Name=5; Synonyms=rbC-II;
CC         IsoId=P22002-5; Sequence=VSP_000908, VSP_000909, VSP_000910;
CC   -!- TISSUE SPECIFICITY: Detected in hippocampus and brain cortex, on
CC       neuronal cell bodies and dendrites, and in post-synaptic density in
CC       brain (at protein level) (PubMed:15140941). Isoforms 4 and 5 are
CC       expressed throughout the central nervous system, with highest levels in
CC       the olfactory bulb and cerebellum. Also expressed in heart, pituitary,
CC       adrenal gland, liver, kidney, and in a much lesser extent in testes and
CC       spleen. {ECO:0000269|PubMed:15140941}.
CC   -!- DEVELOPMENTAL STAGE: Expressed from embryonic day 16 until the adult
CC       stage.
CC   -!- DOMAIN: Each of the four internal repeats contains five hydrophobic
CC       transmembrane segments (S1, S2, S3, S5, S6) and one positively charged
CC       transmembrane segment (S4). S4 segments probably represent the voltage-
CC       sensor and are characterized by a series of positively charged amino
CC       acids at every third position.
CC   -!- DOMAIN: Binding of intracellular calcium through the EF-hand motif
CC       inhibits the opening of the channel. {ECO:0000250|UniProtKB:P15381}.
CC   -!- PTM: Phosphorylation by PKA at Ser-1927 activates the channel (By
CC       similarity). Elevated levels of blood glucose lead to increased
CC       phosphorylation by PKA (By similarity). Is also phosphorylated in vitro
CC       by CaM-kinase II, PKC and CGPK (PubMed:8396138).
CC       {ECO:0000250|UniProtKB:Q01815, ECO:0000269|PubMed:8396138}.
CC   -!- SIMILARITY: Belongs to the calcium channel alpha-1 subunit (TC
CC       1.A.1.11) family. CACNA1C subfamily. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; M59786; AAA85463.1; -; mRNA.
DR   EMBL; M67515; AAA18905.1; -; mRNA.
DR   EMBL; M67516; AAA42016.1; -; mRNA.
DR   EMBL; M91242; AAA41460.1; -; Genomic_DNA.
DR   EMBL; M91240; AAA41460.1; JOINED; Genomic_DNA.
DR   EMBL; M89924; AAA41460.1; JOINED; Genomic_DNA.
DR   EMBL; M91241; AAA41460.1; JOINED; Genomic_DNA.
DR   EMBL; S80558; AAB35528.1; -; mRNA.
DR   EMBL; U31815; AAA89157.1; -; mRNA.
DR   RefSeq; NP_036649.2; NM_012517.2.
DR   PDB; 1VYT; X-ray; 2.60 A; E/F=452-476.
DR   PDBsum; 1VYT; -.
DR   AlphaFoldDB; P22002; -.
DR   SMR; P22002; -.
DR   BioGRID; 246425; 4.
DR   CORUM; P22002; -.
DR   IntAct; P22002; 4.
DR   MINT; P22002; -.
DR   STRING; 10116.ENSRNOP00000048790; -.
DR   BindingDB; P22002; -.
DR   ChEMBL; CHEMBL3762; -.
DR   DrugCentral; P22002; -.
DR   GuidetoPHARMACOLOGY; 529; -.
DR   GlyCosmos; P22002; 4 sites, No reported glycans.
DR   GlyGen; P22002; 4 sites.
DR   iPTMnet; P22002; -.
DR   PhosphoSitePlus; P22002; -.
DR   PaxDb; 10116-ENSRNOP00000009268; -.
DR   ABCD; P22002; 2 sequenced antibodies.
DR   GeneID; 24239; -.
DR   KEGG; rno:24239; -.
DR   UCSC; RGD:2245; rat. [P22002-1]
DR   AGR; RGD:2245; -.
DR   CTD; 775; -.
DR   RGD; 2245; Cacna1c.
DR   eggNOG; KOG2301; Eukaryota.
DR   InParanoid; P22002; -.
DR   OrthoDB; 1110761at2759; -.
DR   PhylomeDB; P22002; -.
DR   Reactome; R-RNO-422356; Regulation of insulin secretion.
DR   Reactome; R-RNO-5576892; Phase 0 - rapid depolarisation.
DR   Reactome; R-RNO-5576893; Phase 2 - plateau phase.
DR   EvolutionaryTrace; P22002; -.
DR   PRO; PR:P22002; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0030424; C:axon; IDA:RGD.
DR   GO; GO:0002095; C:caveolar macromolecular signaling complex; ISO:RGD.
DR   GO; GO:0009986; C:cell surface; IDA:RGD.
DR   GO; GO:0005737; C:cytoplasm; ISO:RGD.
DR   GO; GO:0030425; C:dendrite; IDA:UniProtKB.
DR   GO; GO:0043198; C:dendritic shaft; ISO:RGD.
DR   GO; GO:0098978; C:glutamatergic synapse; IDA:SynGO.
DR   GO; GO:1990454; C:L-type voltage-gated calcium channel complex; IDA:UniProtKB.
DR   GO; GO:0016020; C:membrane; ISO:RGD.
DR   GO; GO:0043025; C:neuronal cell body; IDA:UniProtKB.
DR   GO; GO:0043204; C:perikaryon; IEA:UniProtKB-SubCell.
DR   GO; GO:0005886; C:plasma membrane; ISS:UniProtKB.
DR   GO; GO:0014069; C:postsynaptic density; IDA:UniProtKB.
DR   GO; GO:0098839; C:postsynaptic density membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0045211; C:postsynaptic membrane; IDA:SynGO.
DR   GO; GO:0042734; C:presynaptic membrane; IDA:SynGO.
DR   GO; GO:0032991; C:protein-containing complex; IDA:RGD.
DR   GO; GO:0042383; C:sarcolemma; IDA:RGD.
DR   GO; GO:0030315; C:T-tubule; IDA:RGD.
DR   GO; GO:0005891; C:voltage-gated calcium channel complex; IDA:RGD.
DR   GO; GO:0030018; C:Z disc; IDA:BHF-UCL.
DR   GO; GO:0051393; F:alpha-actinin binding; ISS:BHF-UCL.
DR   GO; GO:0005516; F:calmodulin binding; ISO:RGD.
DR   GO; GO:0019899; F:enzyme binding; ISO:RGD.
DR   GO; GO:0008331; F:high voltage-gated calcium channel activity; IDA:RGD.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0019904; F:protein domain specific binding; IPI:RGD.
DR   GO; GO:0051721; F:protein phosphatase 2A binding; IPI:RGD.
DR   GO; GO:0031369; F:translation initiation factor binding; IPI:RGD.
DR   GO; GO:0044325; F:transmembrane transporter binding; IPI:BHF-UCL.
DR   GO; GO:0005245; F:voltage-gated calcium channel activity; IDA:RGD.
DR   GO; GO:0086056; F:voltage-gated calcium channel activity involved in AV node cell action potential; ISS:BHF-UCL.
DR   GO; GO:0086007; F:voltage-gated calcium channel activity involved in cardiac muscle cell action potential; ISS:BHF-UCL.
DR   GO; GO:1905030; F:voltage-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potential; ISO:RGD.
DR   GO; GO:0007628; P:adult walking behavior; ISO:RGD.
DR   GO; GO:0061564; P:axon development; IEP:RGD.
DR   GO; GO:0070509; P:calcium ion import; IMP:RGD.
DR   GO; GO:0098703; P:calcium ion import across plasma membrane; ISO:RGD.
DR   GO; GO:0070588; P:calcium ion transmembrane transport; ISO:RGD.
DR   GO; GO:0061577; P:calcium ion transmembrane transport via high voltage-gated calcium channel; IDA:UniProtKB.
DR   GO; GO:0006816; P:calcium ion transport; IMP:RGD.
DR   GO; GO:0060402; P:calcium ion transport into cytosol; ISS:UniProtKB.
DR   GO; GO:0017156; P:calcium-ion regulated exocytosis; ISO:RGD.
DR   GO; GO:0043010; P:camera-type eye development; ISO:RGD.
DR   GO; GO:0061337; P:cardiac conduction; ISS:UniProtKB.
DR   GO; GO:0086002; P:cardiac muscle cell action potential involved in contraction; ISS:BHF-UCL.
DR   GO; GO:0086065; P:cell communication involved in cardiac conduction; ISO:RGD.
DR   GO; GO:1904646; P:cellular response to amyloid-beta; IEP:RGD.
DR   GO; GO:0021987; P:cerebral cortex development; IEP:RGD.
DR   GO; GO:0007268; P:chemical synaptic transmission; ISO:RGD.
DR   GO; GO:0022038; P:corpus callosum development; IEP:RGD.
DR   GO; GO:0035115; P:embryonic forelimb morphogenesis; ISO:RGD.
DR   GO; GO:0051649; P:establishment of localization in cell; ISO:RGD.
DR   GO; GO:0006887; P:exocytosis; IMP:RGD.
DR   GO; GO:0042593; P:glucose homeostasis; ISO:RGD.
DR   GO; GO:0030252; P:growth hormone secretion; ISO:RGD.
DR   GO; GO:0007507; P:heart development; ISO:RGD.
DR   GO; GO:0002520; P:immune system development; ISO:RGD.
DR   GO; GO:0030073; P:insulin secretion; ISO:RGD.
DR   GO; GO:0006874; P:intracellular calcium ion homeostasis; ISO:RGD.
DR   GO; GO:0098912; P:membrane depolarization during atrial cardiac muscle cell action potential; ISS:BHF-UCL.
DR   GO; GO:0086045; P:membrane depolarization during AV node cell action potential; ISS:BHF-UCL.
DR   GO; GO:0086012; P:membrane depolarization during cardiac muscle cell action potential; ISS:BHF-UCL.
DR   GO; GO:0021554; P:optic nerve development; IEP:RGD.
DR   GO; GO:0045762; P:positive regulation of adenylate cyclase activity; ISS:UniProtKB.
DR   GO; GO:1904879; P:positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel; IMP:RGD.
DR   GO; GO:0007204; P:positive regulation of cytosolic calcium ion concentration; ISO:RGD.
DR   GO; GO:0032024; P:positive regulation of insulin secretion; IMP:RGD.
DR   GO; GO:1904181; P:positive regulation of membrane depolarization; IMP:RGD.
DR   GO; GO:0008217; P:regulation of blood pressure; ISO:RGD.
DR   GO; GO:0010881; P:regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion; ISS:UniProtKB.
DR   GO; GO:0086091; P:regulation of heart rate by cardiac conduction; ISS:BHF-UCL.
DR   GO; GO:0046620; P:regulation of organ growth; ISO:RGD.
DR   GO; GO:0019229; P:regulation of vasoconstriction; ISO:RGD.
DR   GO; GO:0098911; P:regulation of ventricular cardiac muscle cell action potential; ISS:BHF-UCL.
DR   GO; GO:0097305; P:response to alcohol; IEP:RGD.
DR   GO; GO:0031667; P:response to nutrient levels; IEP:RGD.
DR   GO; GO:0014070; P:response to organic cyclic compound; IDA:RGD.
DR   GO; GO:0006939; P:smooth muscle contraction; ISO:RGD.
DR   GO; GO:0060083; P:smooth muscle contraction involved in micturition; ISO:RGD.
DR   GO; GO:0008542; P:visual learning; ISO:RGD.
DR   Gene3D; 1.10.287.70; -; 4.
DR   Gene3D; 6.10.250.2180; -; 1.
DR   Gene3D; 6.10.250.2500; -; 1.
DR   Gene3D; 1.20.120.350; Voltage-gated potassium channels. Chain C; 4.
DR   InterPro; IPR031688; CAC1F_C.
DR   InterPro; IPR031649; GPHH_dom.
DR   InterPro; IPR005821; Ion_trans_dom.
DR   InterPro; IPR014873; VDCC_a1su_IQ.
DR   InterPro; IPR050599; VDCC_alpha-1_subunit.
DR   InterPro; IPR005451; VDCC_L_a1csu.
DR   InterPro; IPR005446; VDCC_L_a1su.
DR   InterPro; IPR002077; VDCCAlpha1.
DR   InterPro; IPR027359; Volt_channel_dom_sf.
DR   PANTHER; PTHR45628; VOLTAGE-DEPENDENT CALCIUM CHANNEL TYPE A SUBUNIT ALPHA-1; 1.
DR   PANTHER; PTHR45628:SF10; VOLTAGE-DEPENDENT L-TYPE CALCIUM CHANNEL SUBUNIT ALPHA-1C; 1.
DR   Pfam; PF08763; Ca_chan_IQ; 1.
DR   Pfam; PF16885; CAC1F_C; 1.
DR   Pfam; PF16905; GPHH; 1.
DR   Pfam; PF00520; Ion_trans; 4.
DR   PRINTS; PR00167; CACHANNEL.
DR   PRINTS; PR01630; LVDCCALPHA1.
DR   PRINTS; PR01635; LVDCCALPHA1C.
DR   SMART; SM01062; Ca_chan_IQ; 1.
DR   SUPFAM; SSF81324; Voltage-gated potassium channels; 4.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Calcium; Calcium channel;
KW   Calcium transport; Calmodulin-binding; Cell membrane; Cell projection;
KW   Disulfide bond; Glycoprotein; Ion channel; Ion transport; Membrane;
KW   Metal-binding; Phosphoprotein; Postsynaptic cell membrane;
KW   Reference proteome; Repeat; Synapse; Transmembrane; Transmembrane helix;
KW   Transport; Voltage-gated channel.
FT   CHAIN           1..2169
FT                   /note="Voltage-dependent L-type calcium channel subunit
FT                   alpha-1C"
FT                   /id="PRO_0000053931"
FT   TOPO_DOM        1..154
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        155..173
FT                   /note="Helical; Name=S1 of repeat I"
FT                   /evidence="ECO:0000250|UniProtKB:P07293"
FT   TOPO_DOM        174..188
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        189..209
FT                   /note="Helical; Name=S2 of repeat I"
FT                   /evidence="ECO:0000250|UniProtKB:P07293"
FT   TOPO_DOM        210..218
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        219..239
FT                   /note="Helical; Name=S3 of repeat I"
FT                   /evidence="ECO:0000250|UniProtKB:P07293"
FT   TOPO_DOM        240..262
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        263..281
FT                   /note="Helical; Name=S4 of repeat I"
FT                   /evidence="ECO:0000250|UniProtKB:P07293"
FT   TOPO_DOM        282..298
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        299..320
FT                   /note="Helical; Name=S5 of repeat I"
FT                   /evidence="ECO:0000250|UniProtKB:P07293"
FT   TOPO_DOM        321..380
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000305"
FT   INTRAMEM        381..402
FT                   /note="Pore-forming"
FT                   /evidence="ECO:0000250|UniProtKB:P07293"
FT   TOPO_DOM        403..410
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        411..431
FT                   /note="Helical; Name=S6 of repeat I"
FT                   /evidence="ECO:0000250|UniProtKB:P07293"
FT   TOPO_DOM        432..554
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        555..573
FT                   /note="Helical; Name=S1 of repeat II"
FT                   /evidence="ECO:0000250|UniProtKB:P07293"
FT   TOPO_DOM        574..584
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        585..605
FT                   /note="Helical; Name=S2 of repeat II"
FT                   /evidence="ECO:0000250|UniProtKB:P07293"
FT   TOPO_DOM        606..616
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        617..636
FT                   /note="Helical; Name=S3 of repeat II"
FT                   /evidence="ECO:0000250|UniProtKB:P07293"
FT   TOPO_DOM        637..645
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        646..664
FT                   /note="Helical; Name=S4 of repeat II"
FT                   /evidence="ECO:0000250|UniProtKB:P07293"
FT   TOPO_DOM        665..683
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        684..703
FT                   /note="Helical; Name=S5 of repeat II"
FT                   /evidence="ECO:0000250|UniProtKB:P07293"
FT   TOPO_DOM        704..723
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000305"
FT   INTRAMEM        724..745
FT                   /note="Pore-forming"
FT                   /evidence="ECO:0000250|UniProtKB:P07293"
FT   TOPO_DOM        746..755
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        756..775
FT                   /note="Helical; Name=S6 of repeat II"
FT                   /evidence="ECO:0000250|UniProtKB:P07293"
FT   TOPO_DOM        776..930
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        931..949
FT                   /note="Helical; Name=S1 of repeat III"
FT                   /evidence="ECO:0000250|UniProtKB:P07293"
FT   TOPO_DOM        950..961
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        962..981
FT                   /note="Helical; Name=S2 of repeat III"
FT                   /evidence="ECO:0000250|UniProtKB:P07293"
FT   TOPO_DOM        982..997
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        998..1016
FT                   /note="Helical; Name=S3 of repeat III"
FT                   /evidence="ECO:0000250|UniProtKB:P07293"
FT   TOPO_DOM        1017..1023
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        1024..1041
FT                   /note="Helical; Name=S4 of repeat III"
FT                   /evidence="ECO:0000250|UniProtKB:P07293"
FT   TOPO_DOM        1042..1060
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        1061..1080
FT                   /note="Helical; Name=S5 of repeat III"
FT                   /evidence="ECO:0000250|UniProtKB:P07293"
FT   TOPO_DOM        1081..1130
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000305"
FT   INTRAMEM        1131..1151
FT                   /note="Pore-forming"
FT                   /evidence="ECO:0000250|UniProtKB:P07293"
FT   TOPO_DOM        1152..1168
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        1169..1190
FT                   /note="Helical; Name=S6 of repeat III"
FT                   /evidence="ECO:0000250|UniProtKB:P07293"
FT   TOPO_DOM        1191..1248
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        1249..1270
FT                   /note="Helical; Name=S1 of repeat IV"
FT                   /evidence="ECO:0000250|UniProtKB:P07293"
FT   TOPO_DOM        1271..1278
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        1279..1300
FT                   /note="Helical; Name=S2 of repeat IV"
FT                   /evidence="ECO:0000250|UniProtKB:P07293"
FT   TOPO_DOM        1301..1310
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        1311..1330
FT                   /note="Helical; Name=S3 of repeat IV"
FT                   /evidence="ECO:0000250|UniProtKB:P07293"
FT   TOPO_DOM        1331..1353
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        1354..1372
FT                   /note="Helical; Name=S4 of repeat IV"
FT                   /evidence="ECO:0000250|UniProtKB:P07293"
FT   TOPO_DOM        1373..1390
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        1391..1411
FT                   /note="Helical; Name=S5 of repeat IV"
FT                   /evidence="ECO:0000250|UniProtKB:P07293"
FT   TOPO_DOM        1412..1433
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000305"
FT   INTRAMEM        1434..1452
FT                   /note="Pore-forming"
FT                   /evidence="ECO:0000250|UniProtKB:P07293"
FT   TOPO_DOM        1453..1480
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        1481..1505
FT                   /note="Helical; Name=S6 of repeat IV"
FT                   /evidence="ECO:0000250|UniProtKB:P07293"
FT   TOPO_DOM        1506..2169
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000305"
FT   REPEAT          141..438
FT                   /note="I"
FT   REPEAT          540..786
FT                   /note="II"
FT   REPEAT          917..1198
FT                   /note="III"
FT   REPEAT          1235..1508
FT                   /note="IV"
FT   REGION          77..98
FT                   /note="Calmodulin-binding"
FT                   /evidence="ECO:0000250|UniProtKB:Q13936"
FT   REGION          104..128
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          458..475
FT                   /note="AID/alpha-interaction domain; mediates interaction
FT                   with the beta subunit"
FT                   /evidence="ECO:0000269|PubMed:15170217"
FT   REGION          479..511
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          794..891
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          859..906
FT                   /note="Interaction with STAC2"
FT                   /evidence="ECO:0000250|UniProtKB:Q13936"
FT   REGION          1118..1207
FT                   /note="Dihydropyridine binding"
FT                   /evidence="ECO:0000250|UniProtKB:P07293"
FT   REGION          1459..1527
FT                   /note="Dihydropyridine binding"
FT                   /evidence="ECO:0000250|UniProtKB:P07293"
FT   REGION          1473..1515
FT                   /note="Phenylalkylamine binding"
FT                   /evidence="ECO:0000250|UniProtKB:P07293"
FT   REGION          1640..1673
FT                   /note="Calmodulin-binding"
FT                   /evidence="ECO:0000250|UniProtKB:Q13936"
FT   REGION          1640..1667
FT                   /note="Important for interaction with STAC1, STAC2 and
FT                   STAC3"
FT                   /evidence="ECO:0000250|UniProtKB:P15381"
FT   REGION          1646..1666
FT                   /note="Calmodulin-binding IQ region"
FT                   /evidence="ECO:0000250|UniProtKB:Q13936"
FT   REGION          1680..1699
FT                   /note="Important for localization in at the junctional
FT                   membrane"
FT                   /evidence="ECO:0000250|UniProtKB:P15381"
FT   REGION          1761..1793
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1970..1998
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOTIF           391..394
FT                   /note="Selectivity filter of repeat I"
FT                   /evidence="ECO:0000250|UniProtKB:P07293"
FT   MOTIF           734..737
FT                   /note="Selectivity filter of repeat II"
FT                   /evidence="ECO:0000250|UniProtKB:P07293"
FT   MOTIF           1142..1145
FT                   /note="Selectivity filter of repeat III"
FT                   /evidence="ECO:0000250|UniProtKB:P07293"
FT   MOTIF           1443..1446
FT                   /note="Selectivity filter of repeat IV"
FT                   /evidence="ECO:0000250|UniProtKB:P07293"
FT   COMPBIAS        794..839
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        856..872
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1977..1992
FT                   /note="Pro residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   BINDING         393
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /evidence="ECO:0000250|UniProtKB:P07293"
FT   BINDING         736
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /evidence="ECO:0000250|UniProtKB:P07293"
FT   BINDING         1144
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /evidence="ECO:0000250|UniProtKB:P07293"
FT   MOD_RES         499
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q01815"
FT   MOD_RES         506
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q01815"
FT   MOD_RES         838
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q01815"
FT   MOD_RES         845
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         1699
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         1720
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         1927
FT                   /note="Phosphoserine; by PKA"
FT                   /evidence="ECO:0000250|UniProtKB:Q01815"
FT   CARBOHYD        183
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        358
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        1417
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        1468
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        328..356
FT                   /evidence="ECO:0000250|UniProtKB:P07293"
FT   DISULFID        346..362
FT                   /evidence="ECO:0000250|UniProtKB:P07293"
FT   DISULFID        1460..1476
FT                   /evidence="ECO:0000250|UniProtKB:P07293"
FT   VAR_SEQ         1..46
FT                   /note="MIRAFAQPSTPPYQPLSSCLSEDTERKFKGKVVHEAQLNCFYISPG -> MV
FT                   NENTRMYVPEENHQ (in isoform 4 and isoform 5)"
FT                   /evidence="ECO:0000303|PubMed:1648941"
FT                   /id="VSP_000908"
FT   VAR_SEQ         810
FT                   /note="R -> RPAR (in isoform 5)"
FT                   /evidence="ECO:0000303|PubMed:1648941"
FT                   /id="VSP_000909"
FT   VAR_SEQ         964..979
FT                   /note="FYFDIVFTTIFTIEIA -> GNADYVFTSIFTLEII (in isoform 4
FT                   and isoform 5)"
FT                   /evidence="ECO:0000303|PubMed:1648941"
FT                   /id="VSP_000910"
FT   VAR_SEQ         1306..1333
FT                   /note="HYFCDAWNTFDALIVVGSIVDIAITEVH -> GYFSDPSNVFDFLIVIGSII
FT                   AVILSETN (in isoform 1 and isoform 4)"
FT                   /evidence="ECO:0000303|PubMed:1648941,
FT                   ECO:0000303|PubMed:1692134"
FT                   /id="VSP_000911"
FT   VAR_SEQ         1334..1344
FT                   /note="Missing (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:7479909"
FT                   /id="VSP_000912"
FT   CONFLICT        83
FT                   /note="L -> Q (in Ref. 2; AAA18905/AAA42016)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        87
FT                   /note="D -> G (in Ref. 2; AAA18905)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        520
FT                   /note="G -> R (in Ref. 2; AAA18905)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        648..649
FT                   /note="CW -> VL (in Ref. 2; AAA18905/AAA42016)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        678
FT                   /note="L -> V (in Ref. 2; AAA18905/AAA42016)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        769..770
FT                   /note="SP -> CG (in Ref. 2; AAA18905/AAA42016)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        777
FT                   /note="L -> V (in Ref. 2; AAA18905/AAA42016)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        871
FT                   /note="D -> N (in Ref. 2; AAA18905)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1037
FT                   /note="R -> RA (in Ref. 2; AAA18905/AAA42016)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1098
FT                   /note="S -> C (in Ref. 2; AAA18905/AAA42016)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1107
FT                   /note="T -> D (in Ref. 2; AAA18905/AAA42016)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1229
FT                   /note="P -> R (in Ref. 2; AAA18905/AAA42016, 3; no
FT                   nucleotide entry and 6; AAA89157)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1306
FT                   /note="H -> D (in Ref. 5; AAB35528)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1306
FT                   /note="H -> G (in Ref. 2; AAA42016 and 6; AAA89157)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1329
FT                   /note="I -> L (in Ref. 5; AAB35528)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1471
FT                   /note="E -> K (in Ref. 2; AAA18905)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1911
FT                   /note="C -> S (in Ref. 2; AAA18905/AAA42016)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        2084
FT                   /note="K -> N (in Ref. 2; AAA18905)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        2154
FT                   /note="R -> Q (in Ref. 2; AAA42016)"
FT                   /evidence="ECO:0000305"
FT   HELIX           454..474
FT                   /evidence="ECO:0007829|PDB:1VYT"
SQ   SEQUENCE   2169 AA;  243482 MW;  D3ADBD20E4763B69 CRC64;
     MIRAFAQPST PPYQPLSSCL SEDTERKFKG KVVHEAQLNC FYISPGGSNY GSPRPAHANM
     NANAAAGLAP EHIPTPGAAL SWLAAIDAAR QAKLMGSAGN ATISTVSSTQ RKRQQYGKPK
     KQGGTTATRP PRALLCLTLK NPIRRACISI VEWKPFEIII LLTIFANCVA LAIYIPFPED
     DSNATNSNLE RVEYLFLIIF TVEAFLKVIA YGLLFHPNAY LRNGWNLLDF IIVVVGLFSA
     ILEQATKADG ANALGGKGAG FDVKALRAFR VLRPLRLVSG VPSLQVVLNS IIKAMVPLLH
     IALLVLFVII IYAIIGLELF MGKMHKTCYN QEGIIDVPAE EDPSPCALET GHGRQCQNGT
     VCKPGWDGPK HGITNFDNFA FAMLTVFQCI TMEGWTDVLY WMQDAMGYEL PWVYFVSLVI
     FGSFFVLNLV LGVLSGEFSK EREKAKARGD FQKLREKQQL EEDLKGYLDW ITQAEDIDPE
     NEDEGMDEDK PRNMSMPTSE TESVNTENVA GGDIEGENCG ARLAHRISKS KFSRYWRRWN
     RFCRRKCRAA VKSNVFYWLV IFLVFLNTLT IASEHYNQPH WLTEVQDTAN KALLALFTAE
     MLLKMYSLGL QAYFVSLFNR FDCFIVCGGI LETILVETKI MSPLGISCWR CVRLLRIFKI
     TRYWNSLSNL VASLLNSLRS IASLLLLLFL FIIIFSLLGM QLFGGKFNFD EMQTRRSTFD
     NFPQSLLTVF QILTGEDWNS VMYDGIMAYG GPSFPGMLVC IYFIILFISP NYILLNLFLA
     IAVDNLADAE SLTSAQKEEE EEKERKKLAR TASPEKKQEV MEKPAVEESK EEKIELKSIT
     ADGESPPTTK INMDDLQPSE NEDKSPHSNP DTAGEEDEEE PEMPVGPRPR PLSELHLKEK
     AVPMPEASAF FIFSPNNRFR LQCHRIVNDT IFTNLILFFI LLSSISLAAE DPVQHTSFRN
     HILFYFDIVF TTIFTIEIAL KMTAYGAFLH KGSFCRNYFN ILDLLVVSVS LISFGIQSSA
     INVVKILRVL RVLRPLRINR AKGLKHVVQC VFVAIRTIGN IVIVTTLLQF MFACIGVQLF
     KGKLYTCSDS SKQTEAESKG NYITYKTGEV DHPIIQPRSW ENSKFDFDNV LAAMMALFTV
     STFEGWPELL YRSIDSHTED KGPIYNYRVE ISIFFIIYII IIAFFMMNIF VGFVIVTFQE
     QGEQEYKNCE LDKNQRQCVE YALKARPLPR YIPKNQHQYK VWYVVNSTYF EYLMFVLILL
     NTICLAMQHY GQSCLFKIAM NILNMLFTGL FTVEMILKLI AFKPKHYFCD AWNTFDALIV
     VGSIVDIAIT EVHPAEHTQC SPSMSAEENS RISITFFRLF RVMRLVKLLS RGEGIRTLLW
     TFIKSFQALP YVALLIVMLF FIYAVIGMQV FGKIALNDTT EINRNNNFQT FPQAVLLLFR
     CATGEAWQDI MLACMPGKKC APESEPSNST EGETPCGSSF AVFYFISFYM LCAFLIINLF
     VAVIMDNFDY LTRDWSILGP HHLDEFKRIW AEYDPEAKGR IKHLDVVTLL RRIQPPLGFG
     KLCPHRVACK RLVSMNMPLN SDGTVMFNAT LFALVRTALR IKTEGNLEQA NEELRAIIKK
     IWKRTSMKLL DQVVPPAGDD EVTVGKFYAT FLIQEYFRKF KKRKEQGLVG KPSQRNALSL
     QAGLRTLHDI GPEIRRAISG DLTAEEELDK AMKEAVSAAS EDDIFRRAGG LFGNHVSYYQ
     SDSRSNFPQT FATQRPLHIN KTGNNQADTE SPSHEKLVDS TFTPSSYSST GSNANINNAN
     NTALGRFPHP AGYSSTVSTV EGHGPPLSPA VRVQEAAWKL SSKRCHSRES QGATVSQDMF
     PDETRSSVRL SEEVEYCSEP SLLSTDILSY QDDENRQLTC LEEDKREIQP CPKRSFLRSA
     SLGRRASFHL ECLKRQKDQG GDISQKTALP LHLVHHQALA VAGLSPLLQR SHSPSTFPRP
     RPTPPVTPGS RGRPLQPIPT LRLEGAESSE KLNSSFPSIH CSSWSEETTA CSGGSSMARR
     ARPVSLTVPS QAGAPGRQFH GSASSLVEAV LISEGLGQFA QDPKFIEVTT QELADACDMT
     IEEMENAADN ILSGGAQQSP NGTLLPFVNC RDPGQDRAVV PEDESCVYAL GRGRSEEALP
     DSRSYVSNL
//
